{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:31:40Z","timestamp":1774261900466,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1016\/s0891-5849(00)00228-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:18:16Z","timestamp":1027617496000},"page":"1708-1716","source":"Crossref","is-referenced-by-count":409,"title":["Glycoxidation and lipoxidation in atherogenesis"],"prefix":"10.1016","volume":"28","author":[{"given":"John W","family":"Baynes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne R","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0891-5849(00)00228-8_BIB1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1079\/PNS19990022","article-title":"Lipoprotein atherogenicity","volume":"58","author":"Griffin","year":"1999","journal-title":"Prog. Nutr. Soc."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB2","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/S0022-2275(20)37467-8","article-title":"Aggregation and fusion of modified low density lipoprotein","volume":"37","author":"Pentikainen","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB3","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1074\/jbc.272.21.13597","article-title":"M; Berliner, J. A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte\/endothelial interactions and evidence for their presence in vivo","volume":"272","author":"Watson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF02253564","article-title":"The isoprostanes","volume":"6","author":"Liu","year":"1999","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.ATV.10.3.336","article-title":"Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits","volume":"10","author":"Rosenfeld","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB6","doi-asserted-by":"crossref","unstructured":"Requena, J. R.; Fu, M-X.; Ahmed, M. U.; Jenkins, A. J.; Lyons, T. J.; Thorpe, S. R. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 11(Suppl. 5):48\u201353; 1996.","DOI":"10.1093\/ndt\/11.supp5.48"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1021\/tx960157y","article-title":"Levuglandin E2-protein adducts in human plasma and vasculature","volume":"10","author":"Salomon","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","article-title":"The role of oxidative stress in diabetic complications","volume":"48","author":"Thorpe","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB9","first-page":"2018","article-title":"The other side of metabolism","volume":"61","author":"Golubev","year":"1996","journal-title":"Biokhimiia"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0021-9150(98)00149-X","article-title":"Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions","volume":"141","author":"Sakata","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0014-5793(99)00122-2","article-title":"2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery","volume":"445","author":"Miyata","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB12","doi-asserted-by":"crossref","first-page":"9151","DOI":"10.1073\/pnas.91.19.9151","article-title":"Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus","volume":"91","author":"Valera","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0891-5849(92)90181-F","article-title":"The role of lipid peroxidation and antioxidants in oxidative modification of LDL","volume":"13","author":"Esterbauer","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0009-3084(98)00091-7","article-title":"Linoleic acid peroxidation\u2014the dominant lipid peroxidation process in low density lipoprotein\u2014and its relationship to chronic diseases","volume":"95","author":"Spiteller","year":"1998","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/tx960094j","article-title":"Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal","volume":"9","author":"Sayre","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB17","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1073\/pnas.95.14.7975","article-title":"Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine","volume":"95","author":"Tsai","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB18","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1073\/pnas.95.9.4882","article-title":"Protein-bound acrolein","volume":"95","author":"Uchida","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB19","doi-asserted-by":"crossref","first-page":"20406","DOI":"10.1074\/jbc.274.29.20406","article-title":"Formation of N\u03b5-(hexanoyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification","volume":"274","author":"Kato","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB20","first-page":"B265","article-title":"Lipofuscin","volume":"106","author":"Terman","year":"1998","journal-title":"AMPIS"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/anie.199005653","article-title":"New aspects of the Maillard reaction in foods and in the human body","volume":"29","author":"Ledl","year":"1990","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB22","first-page":"85","article-title":"The chemistry of the Maillard reaction under physiological conditions","volume":"304","author":"Njoroge","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0306-3623(95)02054-3","article-title":"Pharmacology of methylglyoxal","volume":"27","author":"Thornalley","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0026-0495(97)90240-7","article-title":"Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts","volume":"46","author":"Lal","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB25","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/S0021-9258(19)84914-1","article-title":"Aging of proteins","volume":"264","author":"Hayase","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB26","doi-asserted-by":"crossref","first-page":"32299","DOI":"10.1016\/S0021-9258(18)31635-1","article-title":"Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N\u03b1-acetyl-arginine, N\u03b1-aceylcysteine, and N\u03b1-acetyl-lysine, and bovine serum albumin","volume":"269","author":"Lo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB27","doi-asserted-by":"crossref","unstructured":"Niwa, T.; Katsuzaki, T.; Miyazaki, S.; Miyazaki, T.; Ishizaki, Y.; Hayase, F.; Tatemichi, N.; Takei, Y. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J. Clin. Invest. 99:1272\u20131280.","DOI":"10.1172\/JCI119285"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abbi.1997.0195","article-title":"Protein modification by methylglyoxal","volume":"344","author":"Shipanova","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB29","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1074\/jbc.274.26.18492","article-title":"Methylglyoxal modification of protein","volume":"274","author":"Oya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB30","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1016\/S0021-9258(20)88225-8","article-title":"R; Monnier, V. M. Structure elucidation of a senescence cross-link from human extracellular matrix","volume":"264","author":"Sell","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB31","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1016\/S0021-9258(18)99007-1","article-title":"Formation of pentosidine during nonenzymatic browning of proteins by glucose","volume":"266","author":"Dyer","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/bbrc.1996.1308","article-title":"Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo","volume":"226","author":"Obayashi","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/bbrc.1997.6262","article-title":"Acid-stable fluorescent advanced glycation end products","volume":"232","author":"Nakamura","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB34","doi-asserted-by":"crossref","first-page":"20796","DOI":"10.1074\/jbc.274.30.20796","article-title":"Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis","volume":"274","author":"Tessier","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB35","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1172\/JCI116481","article-title":"Accumulation of Maillard reaction products in skin collagen in diabetes and aging","volume":"91","author":"Dyer","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj3240565","article-title":"N\u03b5-(carboxyethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins","volume":"324","author":"Ahmed","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB37","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","article-title":"The advanced glycation end product, N\u03f5-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions","volume":"271","author":"Fu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB38","doi-asserted-by":"crossref","first-page":"18714","DOI":"10.1074\/jbc.273.30.18714","article-title":"Role of the Maillard reaction in aging of tissue proteins","volume":"273","author":"Brinkmann Frye","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/abbi.1999.1291","article-title":"Protein crosslinking by the Maillard reaction; dicarbonyl-derived imidazolium crosslinks in aging and diabetes","volume":"368","author":"Chellan","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB40","first-page":"1139","article-title":"Chemical modification of proteins by methylglyoxal","volume":"44","author":"Degenhardt","year":"1998","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-9150(97)00238-4","article-title":"Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage","volume":"136","author":"Meng","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI3042","article-title":"The myeloperoxidase system of human phagocytes generates N\u03b5-(carboxymethyl)lysine on proteins","volume":"104","author":"Anderson","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB43","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1074\/jbc.272.6.3520","article-title":"Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques","volume":"272","author":"Leeuwenburgh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1096\/fasebj.13.10.1113","article-title":"Mass spectrometric quantification of amino acid oxidation product in proteins","volume":"13","author":"Heinecke","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB45","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1074\/jbc.274.16.10903","article-title":"A modification of apoliprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein","volume":"274","author":"Martens","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10715769900300021","article-title":"Glutathione (GSH) and the toxicity of oxidized low density lipoprotein to human monocyte-macrophages","volume":"30","author":"Hardwick","year":"1999","journal-title":"Free Radic. Res."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products","volume":"19","author":"Schmidt","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB48","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0008-6363(97)00233-2","article-title":"AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept","volume":"37","author":"Bierhaus","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/bbrc.1999.0898","article-title":"Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding","volume":"260","author":"Saxena","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB50","doi-asserted-by":"crossref","first-page":"25272","DOI":"10.1074\/jbc.273.39.25272","article-title":"Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation","volume":"273","author":"Lee","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00041433-199706000-00008","article-title":"Lipoprotein glycation and its metabolic consequences","volume":"8","author":"Lyons","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB52","first-page":"365","article-title":"Glycation, oxidation, and lipoxidation in the development of the complications of diabetes","volume":"5","author":"Lyons","year":"1997","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB53","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF03401604","article-title":"Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE)","volume":"1","author":"Vlassara","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0047-6374(99)00011-1","article-title":"Receptors for proteins modified by advanced glycation endproducts (AGE)\u2014their functional role in atherosclerosis","volume":"15","author":"Sano","year":"1999","journal-title":"Mech. Ageing. Dev."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB55","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB56","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0891-5849(98)00302-5","article-title":"Can antioxidant vitamins materially reduce oxidative damage in humans?","volume":"26","author":"McCall","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB57","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.ATV.15.10.1616","article-title":"Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate","volume":"15","author":"Suarna","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB58","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1126\/science.3487117","article-title":"Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking","volume":"232","author":"Brownlee","year":"1986","journal-title":"Science"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB59","series-title":"Drugs, diet and disease, vol. 2","first-page":"203","article-title":"Reactive oxygen in the aetiology and complications of diabetes","author":"Baynes","year":"1995"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000170199","article-title":"Advanced glycosylation endproducts in diabetic renal disease","volume":"13","author":"Bucala","year":"1995","journal-title":"Blood Purif."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB61","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2337\/diabetes.46.5.895","article-title":"Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation","volume":"46","author":"Nakamura","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB62","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s001250051181","article-title":"A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes","volume":"42","author":"Soulis","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB63","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/en.138.5.1886","article-title":"Inhibitor effects of tenilsetam on the Maillard reaction","volume":"138","author":"Shoda","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB64","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1074\/jbc.272.9.5430","article-title":"In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways","volume":"272","author":"Booth","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.1999.0371","article-title":"Amadorins","volume":"257","author":"Khalifah","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB66","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1073\/pnas.91.20.9441","article-title":"Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency","volume":"91","author":"Bucala","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9150(97)00192-5","article-title":"Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit","volume":"136","author":"Panagiotopoulos","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB68","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1073\/pnas.95.3.1301","article-title":"Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy","volume":"95","author":"Corman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB69","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.ATV.15.3.367","article-title":"Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL","volume":"15","author":"Philis-Tsimikas","year":"1995","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB70","doi-asserted-by":"crossref","first-page":"25F","DOI":"10.1016\/S0002-9149(99)00211-8","article-title":"Hypertriglyceridemia, insulin resistance, and the metabolic syndrome","volume":"83","author":"Grundy","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diacare.18.2.258","article-title":"Hyperglycemia and microvascular and macrovascular disease in diabetes","volume":"18","author":"Klein","year":"1995","journal-title":"Diab. Care"},{"key":"10.1016\/S0891-5849(00)00228-8_BIB72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj3220317","article-title":"Quantitation of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein","volume":"322","author":"Requena","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/S0891-5849(00)00228-8_BIB73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1172\/JCI119599","article-title":"Age-dependent accumulation of ortho-tyrosine and methionine sulfoxide in human skin collagen is not increased in diabetes","volume":"100","author":"Wells-Knecht","year":"1997","journal-title":"J. Clin. Invest."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584900002288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584900002288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T02:19:50Z","timestamp":1620526790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584900002288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0891584900002288"],"URL":"https:\/\/doi.org\/10.1016\/s0891-5849(00)00228-8","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}